تحميل...
Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
PURPOSE OF REVIEW: With the advent of cancer immunotherapy and immune checkpoint inhibitors, patients with malignancies can now achieve durable remissions for conditions previously described as terminal. However, immune-related adverse events (irAEs) associated with cancer immunotherapy have become...
محفوظ في:
| الحاوية / القاعدة: | Curr Rheumatol Rep |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
2018
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6488223/ https://ncbi.nlm.nih.gov/pubmed/30191417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11926-018-0770-0 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|